PEAPX
Price
$25.01
Change
-$0.45 (-1.77%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

PEAPX vs RNWFX

Header iconPEAPX vs RNWFX Comparison
Open Charts PEAPX vs RNWFXBanner chart's image
Principal Glb Emerging Markets R3
Price$25.01
Change-$0.45 (-1.77%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PEAPX vs RNWFX Comparison Chart
Loading...
VS
PEAPX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEAPX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. PEAPX (518M). PEAPX pays higher dividends than RNWFX: PEAPX (1.63) vs RNWFX (1.51). PEAPX was incepted earlier than RNWFX: PEAPX (24 years) vs RNWFX (22 years). PEAPX (32.40) and RNWFX (32.00) have comparable annual turnover. PEAPX has a lower initial minimum investment than RNWFX: PEAPX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. PEAPX (9.37). RNWFX return over 5 years is better than : 22.38 vs. PEAPX (10.71).
PEAPXRNWFXPEAPX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years22 years-
Gain YTD4.8607.24567%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets518M60.1B1%
Annual Yield % from dividends1.631.51108%
Returns for 1 year9.3711.5381%
Returns for 3 years-20.31-15.44132%
Returns for 5 years10.7122.3848%
Returns for 10 years3.7435.7110%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio